e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex
Logan A.G., Tkacova R., Perlikowski S.M., Leung R.S., Tisler A., Floras J.S., Bradley T.D.
Source:
Eur Respir J 2003; 21: 241-247
Journal Issue:
February
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Logan A.G., Tkacova R., Perlikowski S.M., Leung R.S., Tisler A., Floras J.S., Bradley T.D.. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Static lung volumes and spirometry measurements
The physiology of breathlessness
Related content which might interest you:
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
Source: Eur Respir J 2006; 27: 128-135
Year: 2006
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Exacerbation of sleep-apnoea related nocturnal blood-pressure fluctuations in hypertensive subjects
Source: Eur Respir J 2002; 20: 151-157
Year: 2002
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Source: Eur Respir J 2003; 21: 509-514
Year: 2003
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans
Source: Eur Respir J 2011; 37: 119-128
Year: 2011
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Source: Eur Respir Rev 2007; 16: 115-124
Year: 2007
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Source: Eur Respir J 2007; 29: 720-727
Year: 2007
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure
Source: Eur Respir J, 50 (4) 1701822; 10.1183/13993003.01822-2017
Year: 2017
Sleep-disordered breathing and hormones
Source: Eur Respir J 2003; 22: 161-172
Year: 2003
Pathophysiology of obstructive sleep apnoea: from clinical closing pressure to ventilatory
Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more
Year: 2019
Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005
Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 574s
Year: 2006
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Pathophysiology of central sleep apnea
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept